Trials / Completed
CompletedNCT00364468
Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients
A Randomized Dose Finding Study of KRN125 (Pegfilgrastim) for the Treatment of Chemotherapy - Induced Neutropenia in Malignant Lymphoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 107 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
To assess the duration of severe neutropenia in cycle 1 of chemotherapy after treatment with a single injection of KRN125 or multiple daily injections of filgrastim.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pegfilgrastim |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2006-08-15
- Last updated
- 2017-03-03
Locations
6 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00364468. Inclusion in this directory is not an endorsement.